MERTK and melanoma: SAM also identified MERTK—a receptor tyrosine kinase correlating with disease progression in melanoma (Schlegel et al, 2013) and not detected in the full proteome measurements—to be differentially expressed between the different Kinobeads Subtypes (q‐value < 0.01).